kt 5823 has been researched along with ro 32-0432 in 1 studies
| Studies (kt 5823) | Trials (kt 5823) | Recent Studies (post-2010) (kt 5823) | Studies (ro 32-0432) | Trials (ro 32-0432) | Recent Studies (post-2010) (ro 32-0432) |
|---|---|---|---|---|---|
| 317 | 0 | 59 | 56 | 0 | 13 |
| Protein | Taxonomy | kt 5823 (IC50) | ro 32-0432 (IC50) |
|---|---|---|---|
| Protein kinase C alpha type | Homo sapiens (human) | 0.022 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arandarcikaite, O; Barauskaite, J; Borutaite, V; Brown, GC; Jekabsone, A; Morkuniene, R | 1 |
1 other study(ies) available for kt 5823 and ro 32-0432
| Article | Year |
|---|---|
Nitric oxide protects the heart from ischemia-induced apoptosis and mitochondrial damage via protein kinase G mediated blockage of permeability transition and cytochrome c release.
Topics: Animals; Apoptosis; Carbazoles; Cyclic GMP-Dependent Protein Kinases; Cytochromes c; Indoles; Male; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Ischemia; Nitric Oxide; Nitric Oxide Donors; Protein Kinase Inhibitors; Pyrroles; Rats; Rats, Wistar; Triazenes | 2009 |